Bone
14 Jan 2008
Milk and Milk Products (Dairy Products)
Children and adolescents should be encouraged to consume milk products because this is the period of their lives in which they are building their peak…
Blood
11 Jan 2008
Cord Blood Viable Option for Kids with Life-Threatening Metabolic Disorders
Children born with inherited metabolic disorders that cause organ failure and early death can be treated successfully with umbilical cord blood transplants from unrelated donors and, in some cases go on to live for many years, according to a study led by Duke University Medical Center researchers. Umbilical cord blood…
Blood
08 Jan 2008
Introduction to Clinical Trials
Clinical trials are a type of clinical research used to investigate the effectiveness of medicines, prevention programs and diagnostic techniques.
Bone
10 Dec 2007
Spinal Anaesthesia
For information on spinal anaesthesia or epidural anaesthesia.
Bone
26 Nov 2007
Best Methods for Removing Injured Players from the Field
The 15 minutes it took to remove Buffalo Bills player Kevin Everett off the field after he suffered a spinal cord injury may seem like a long time for someone needing acute medical care, but in fact, those minutes underscore how critical it is to carefully move a player with…
Bone
16 Nov 2007
COSA ASM 2007 Highlights
The 34th COSA ASM offered a series of stimulating and exciting presentations from international and national experts covering the many disciplines of oncology research and clinical practice. The conference was held at the Adelaide Convention Centre on November 14-16, 2007. Some of the presentations that took place are summarised here.
Blood
16 Nov 2007
New Anti-cancer Drug Now Subsidised by the Government
A government committee has recently announced its addition of Velcade (bortezomib) to the Australian Pharmaceutical Benefits Scheme (PBS). Velcade is a novel drug used to treat an aggressive blood cancer called multiple myeloma. Although the treatment is worth several thousands of dollars, patients can now access the drug at heavily…
Blood
16 Nov 2007
New Hope for Patients with Myeloma as Velcade is Added to the PBS
A novel therapy for advanced and progressive stages of multiple myeloma has become available on the Australian Pharmaceutical Benefits Scheme from November 1st 2007. This is fantastic news for sufferers of this rare and debilitating haematological cancer, whom normally face a poor prognosis without treatment. Multiple myeloma (MM) is a…
Bone
30 Oct 2007
Facial Characteristics offer Insights into Genetic Conditions
The general public easily recognises the faces of people with Down’s syndrome, but there are over 700 genetic conditions where there are characteristic facial features: the eyes may be set further apart than usual, the nose shorter and the ears set lower down on the head along with many other…